Biomarkers in hodgkin’s lymphoma

Basit Öğe Kaydı
dc.contributor.authorDemir, Esin
dc.contributor.authorYılmaz, Burak
dc.contributor.authorGündüz, Mehmet
dc.contributor.authorGündüz, Esra
dc.date.accessioned2025-10-24T18:06:54Z
dc.date.available2025-10-24T18:06:54Z
dc.date.issued2014
dc.departmentMalatya Turgut Özal Üniversitesi
dc.description.abstractLymphoma is a type of hematological cancer which occurs in the immune system, and specifically starts in lymphocytes. Lymphoma is basically of two types: Hodgkin’s and non-Hodgkin’s lymphoma (NHL). This chapter will specifically focus on Hodgkin’s lymphoma (HL), whose subtypes are nodular lymphocyte-predominant Hodgkin’s lymphoma (NLPHL) and classical Hodgkin’s lymphoma (cHL). The characteristic cell types involved in these subtypes are different from each other. Biomarkers are another critical factor in making the correct identification of each subtype. Biomarkers can be categorized into different groups such as origin-related, chromosomal, cytokine, chemokine, and some important pathways-related markers. These biomarkers are not only important to distinguish subtypes but also critical to determine further treatment strategies for disease. Due to the importance of biomarker knowledge, we have reviewed significant HL biomarkers in this chapter. © 2018 Elsevier B.V., All rights reserved.
dc.identifier.endpage870
dc.identifier.isbn9781466584280
dc.identifier.isbn9781466584297
dc.identifier.scopus2-s2.0-85054633119
dc.identifier.scopusqualityN/A
dc.identifier.startpage849
dc.identifier.urihttps://hdl.handle.net/20.500.12899/3274
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherCRC Press
dc.relation.publicationcategoryKitap Bölümü - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzScopus_20251023
dc.subjectBiomarker
dc.subjectCHL
dc.subjectHodgkin’s lymphoma
dc.subjectNLPHL
dc.subjectPathway
dc.subjectTreatment
dc.titleBiomarkers in hodgkin’s lymphoma
dc.typeBook Chapter

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu